GranataBio Corporation

Syntium Pharmaceuticals Inc. is a biopharmaceutical company based in Boston, MA, focused on in-licensing early stage candidate drugs and advancing them through clinical development up to Proof-of-Concept in target patient populations. The company actively conducts and funds the clinical development of these candidates before out-licensing them once they achieve Proof-of-Concept data. With a commitment to innovation, Syntium has recently strengthened its team by adding experienced drug developers. This enhances their capabilities in moving promising drug candidates down the value chain towards successful commercialization. Generated from the website

Genome Therapeutics Corp is a biotechnology company based in Waltham, MA, focused on advancing genomic medicine. The company is dedicated to leveraging innovative technologies to enhance therapeutic solutions and improve patient outcomes. With a commitment to research and development, Genome Therapeutics Corp aims to pioneer breakthroughs in genetic therapies. Their work is poised to contribute significantly to the evolving landscape of healthcare and personalized medicine. Generated from the website